Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

The new herbal shampoo is effective, safe, and more affordable than other products.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tislelizumab can cause cutaneous lupus erythematosus.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

TSPO might help treat anxiety and depression.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

TAK-279 effectively reduces psoriasis symptoms and is safe.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.